A role for SPHK1 and S1P in drug resistance in gastroesophageal cancer is consistent with many previous investigations, which have suggested a pathogenic role in several cancer types including gastric cancer [21], where SPHK1 overexpression is observed in tumour cells and associated with increased stage and poor survival [20]. The gene discussed is SPHK1; the disease is neoplasm.